Form D · Biotechnology
Rapid Pathogen Screening Inc
Sarasota, FL · CIK 0001338026
Offering snapshot reported Jul 22, 2013 · SEC filing
- Reported sold
- $2.28M Offering amount: $15M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 8, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$30,000 → $2,284,125
- Reported investors1 → 25
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 22, 2013 | Amendment | $2,284,125 | $2,254,125vs Oct 22, 2012 | 25 | SEC filing |
| Jul 22, 2013 | Initial | $6,250,000 | No comparison | 1 | SEC filing |
| Oct 22, 2012 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Oct 10, 2012 | Amendment | $6,790,950 | $1,610,950vs Dec 2, 2011 | 57 | SEC filing |
| Dec 2, 2011 | Amendment | $5,180,000 | $5,180,000vs Sep 14, 2010 | 36 | SEC filing |
| Sep 14, 2010 | Initial | $0 | No comparison | 1 | SEC filing |
| Feb 9, 2010 | Amendment | $15,000,000 | No comparison | 71 | SEC filing |
| Feb 9, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 8, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-185900
The offering is completed.
Source: Form D, filed Jul 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas W. Berg | Director |
| Stephen R. La Neve | Director |
| Jules Musinger | Director |
| Thomas Orsini | Director |
| Caroline Popper | Director |
| William Rueckert | Director |
| Hanjoon Ryu | Director |
| Charles T. Saldarini | Director |
| Robert Sambursky | Director, Executive |
| Jose Sambursky | Director |
| Daniel Sambursky | Director |
| Michael Strauss | Director |
| Robert Van Dine | Director, Executive |
| J. Scott Womble | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7227 Delainey Court
Sarasota, FL, 34240
Sarasota, FL, 34240